IND FARMA ESPECIAL has a total of 25 patent applications. Its first patent ever was published in 1980. It filed its patents most often in Spain, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are GRANDI GUIDO, CT DE IMMUNOLOGIA MOLECULAR and SCHENK DALE B.
# | Country | Total Patents | |
---|---|---|---|
#1 | Spain | 8 | |
#2 | Australia | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Japan | 2 | |
#8 | France | 1 | |
#9 | Mexico | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Environmental technology | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Palacios Pelaez Ricardo | 11 |
#2 | Martinez Quesada Jorge | 10 |
#3 | Martinez Garate Alberto | 10 |
#4 | Pelaez Ricardo Palacios | 5 |
#5 | Garate Alberto Martinez | 4 |
#6 | Quesada Jorge Martinez | 4 |
#7 | Horuhe Maruteinesu Kesaada | 2 |
#8 | Rikarudo Parashiosu Peraesu | 2 |
#9 | Asturias Ortega Juan Andres | 2 |
#10 | Aruberuto Maruteinesu Garate | 2 |
Publication | Filing date | Title |
---|---|---|
US6471966B1 | Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof | |
AU4302697A | Anti-inflammatory pharmaceutical formulation | |
ES2076895A1 | Fimbrias-adhesinas of type 1 and p isolated from new strains of e. coli, procedure for their obtaining and applications. | |
ES2081255A1 | Application of the receptor proteins of autoincompatibility (slsg) of plants for the treatment of allergic diseases. | |
ES8403904A1 | A procedure for the preparation of acicloguanosin. | |
ES8300786A1 | A procedure for the preparation of 6 & -halo substituted-pregna-1,4-dien-3-onas and pregna 4-in-3-onas. |